Get a free book sample
Fill in your information and the book will be sent to your email in no time
Get a free book sample
Fill in your information and the book will be sent to your email in no time
Book a free demo
Fill in your information and we will contact you as soon as possible
Get a quote
Fill in your information and we will contact you as soon as possible
With the help of decision support tools, clinicians can differentiate between vector-borne diseases during a season where more people are at risk. A decision support system uses two or more items of patient data to generate case-specific advice. In practical terms, the output of such systems is used to arrive at a specific diagnosis. Although none of these systems can “make” a diagnosis, they are capable of generating a list of diseases that are compatible with a patient’s epidemiological background, signs, symptoms, and laboratory findings.
…
Stephen A. Berger is co-founder and medical director of GIDEON, the Global Infectious Disease and Epidemiology Online Network.
For example, if a group of American adults is experiencing severe illness, cough and fever, the most likely diagnosis is COVID-19. In this scenario, an infectious disease database platform ranks COVID-19 “number 1,” with a statistical likelihood of 87%. However, the program also lists an additional 76 infectious diseases. (Influenza is the second most likely diagnosis, with a probability of 8%.)
…
Stephen A. Berger, MD, is co-founder and medical director of GIDEON, the Global Infectious Disease and Epidemiology Online Network.
… if you want to make your voice heard at a protest, know that there are ways to lower your risk of catching—or spreading—COVID-19
…
“Assume that the stranger standing next to you is spreading the virus,” adds Stephen Berger, M.D., infectious disease expert and founder of the Global Infectious Diseases and Epidemiology Network (GIDEON).
Think long and hard before deciding to meet up with friends or family. Your own health is a priority, and you want to be considerate of others, too.
Contracting COVID-19 is a lot about the company you keep, explains Stephen Berger, MD, infectious disease expert, and co-founder of GIDEON (Global Infectious Diseases and Epidemiology Network). But the places you go can make a difference, too.
“Infectious material enters our body through our mouth or nose — either because you were within a few feet of a human carrier, or because something brought this material to the area of our face,” Dr. Berger says.
Science publications about COVID-19
…
“The volume is so great that what’s being published on COVID is equal to all the other research that is usually being put on infectious disease as a whole,” says Uri Blackman, CEO of GIDEON Informatics, which has put out medical databases since 1992.
“Lavatories are, unfortunately, ideal for the transmission of COVID-19. They are closed and poorly ventilated,” says Stephen Berger, M.D., an infectious disease expert and co-founder of GIDEON, the Global Infectious Diseases and Epidemiology Network.
“Urinals and sinks are crowded together, and partitions rarely extend upward to shield someone’s face. Although toilet stalls are isolated, droplets and aerosols will continue to linger there, several minutes after the last user has left,” he says.
“According to the Global Infectious Diseases and Epidemiology Online Network (GIDEON), as of 19 April, there are 24 countries/territories that have not reported any cases of COVID-19. These are mostly small Pacific Island Nations, however also includes two countries in Europe – Tajikistan and Turkmenistan.”
“During the recent wave of protest gatherings, we’ve witnessed total abandonment of social distancing,” said Stephen Berger, an infectious disease expert, and co-founder of the Global Infectious Diseases and Epidemiology Network (GIDEON).
“The center of a large crowd is no different than a sealed-off, unventilated room filled with potentially infected individuals – many holding large signs which will block the flow of clean air,” Berger told Yahoo Finance.
Experts say it’s possible we may see an increase in cases if people are unable or unwilling to physically distance.
“The center of a large crowd is no different than a sealed off, unventilated room filled with potentially infected individuals — many holding large signs which will block the flow of clean air,” said Dr. Stephen Berger, an infectious disease expert and co-founder of GIDEON (Global Infectious Diseases and Epidemiology Network).
“If even one carrier of COVID-19 was present at these gatherings, we can expect to see a wave of cases appearing during the next 2 to 14 days. Most will begin to experience symptoms 5 to 6 days after the event,” he said.
But you may be able to get COVID-19 through your eyes, as well. “Theoretically, the virus of COVID-19 could arrive to the eyes and travel down through our tear ducts into the nose and throat,” explains Stephen Berger, M.D., a double board-certified infectious disease specialist, microbiologist, and founder of GIDEON, the Global Infectious Disease and Epidemiology Online Network. This route of infection hasn’t been proven but is suspected to be how some people get the virus.
Dr. Stephen Berger, an infectious disease expert and co-founder of the Global Infectious Diseases and Epidemiology Network (GIDEON), also stressed the importance of 6-foot spacing.
He said a “large, open, and ventilated” space is preferred — outdoors, if possible.
“Before dining in a restaurant, the big question to ask is, simply, ‘Do they adhere to social distancing?’” Berger told Healthline. “Before sitting down and asking for a menu, check to confirm that the restaurant staff is wearing masks and that these masks cover their noses and mouths.”
To estimate this risk, we must start by drawing maps: where are these species and how much are they in contact with human populations? This is the study project that Timothy Poisot initiated by combining mathematical models, artificial intelligence, and ecology.
To better understand these zoonoses—diseases that are transmitted from animals to humans—researchers drew data from the large epidemiological inventory of human diseases identified, the GIDEON database.
(Translated from French by Google)
Cookie | Duration | Description |
---|---|---|
cookielawinfo-checkbox-analytics | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics". |
cookielawinfo-checkbox-functional | 11 months | The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional". |
cookielawinfo-checkbox-necessary | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary". |
cookielawinfo-checkbox-others | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other. |
cookielawinfo-checkbox-performance | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance". |
viewed_cookie_policy | 11 months | The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data. |